This is the next-generation PDM role where AI fluency isnt a nice-to-have — its core to the job. Were looking for someone who can harness AI tools and insights to drive smarter, faster, and more impactful
Company Description We are SGS – the worlds leading testing, inspection and certification company. We are recognized as the global benchmark for sustainability, quality and integrity. Our 99,500 employees operate a network of 2,500 offices and
Job summary Identifies, evaluates, develops and closes new customers and expands business at existing customers. Identifies and assists in progressing biopharmaceutical business opportunities including new scientific and strategic partnerships, collaborations, licensing opportunities, joint ventures and alliances. Establishes
Elastic, the Search AI Company, enables everyone to find the answers they need in real time, using all their data, at scale — unleashing the potential of businesses and people. The Elastic Search AI Platform, used
Who is Sonar? Sonar is driving the future of agent-centric software development. As the leader in AI code review and verification, we solve a critical problem: ensuring that software generated by AI-assisted developers or autonomous agents is
Were Hiring: Chief Product Officer (CPO) / Deputy IT Director Industry: FinTech / Payments Location: Switzerland Compensation: CHF 200,000–240,000 gross per year + Performance Bonus We are partnering with a rapidly growing international FinTech & Payments
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement.read on In 2015, we pioneered a “moneyball for biotech”
At DuPont, our purpose is to empower the world with essential innovations to thrive. We work on things that matter. Whether it’s providing clean water to more than a billion people on the planet, producing materials
At DuPont, our purpose is to empower the world with essential innovations to thrive. We work on things that matter. Whether it’s providing clean water to more than a billion people on the planet, producing materials
We are the people who give possibilities purpose BD is one of the largest global medical technology companies in the world. Advancing the world of health is our Purpose, and it’s no small feat. It takes
Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of
We are the people who give possibilities purpose BD is one of the largest global medical technology companies in the world. Advancing the world of health is our Purpose, and it’s no small feat. It takes
We are rebuilding biotech for the AI era. When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected
Seniority Level: Do you have what it takes to define the future sourcing strategy for key business services categories, representing hundreds of millions in annual spend? Can you lead strategic negotiations to create successful partnerships for both
Do you want to dive in the fast-growing industry of drones and get a rewarding experience in a dynamic scale-up environment? At Flyability, we believe that robots should be sent into hazardous places and dangerous environments
Job Description Global Vice President, Feed Additives & Ingredients (FAI) Location: Rolle, Switzerland preferred Business: ADM Animal Nutrition Reports to: SVP, Global Nutrition Operations Work that Feeds the World At ADM, we work across food, agriculture
About the Role Reporting to the VP, CFO Global Cocoa, this position is the right hand of the VP, Cocoa Manufacturing, driving the decision-making process by focusing on the financial performance of operations as well as supply chain.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)